Search

Fucicort

Fucicort

betamethasone + fusidic acid

Manufacturer:

LEO Pharma

Distributor:

DKSH
Concise Prescribing Info
Contents
Per g Fusidic acid 20 mg, betamethasone valerate 1 mg
Indications/Uses
Inflammatory dermatoses (including atopic eczema, discoid eczema, stasis eczema, seborrhoeic dermatitis, contact dermatitis, lichen simplex chronicus, psoriasis, discoid lupus erythematosus) where bacterial infection is present or likely to occur.
Click to view Fucicort detailed prescribing information
Dosage/Direction for Use
Uncovered lesions Apply bd-tds. Covered lesions Less frequent application may be adequate.
Click to view Fucicort detailed prescribing information
Overdosage
View Fucicort overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity. Systemic fungal infections; primary fungal, viral or bacterial skin infections, either untreated or uncontrolled by appropriate treatment; skin manifestations in relation to TB, either untreated or uncontrolled by appropriate treatment; perioral dermatitis & rosacea.
Click to view Fucicort detailed prescribing information
Special Precautions
Avoid long-term continuous topical therapy; contact to eyes; large amounts & occlusion; contact w/ open wounds & mucous membranes; applying on the breast. Limit therapy to no more than 14 days at a time to minimise risk of developing resistance. May be associated w/ increased susceptibility to infection, aggravation of existing infection, & activation of latent infection. Contains cetostearyl alcohol & chlorocresol. Pregnancy. Childn. Fusidic acid: Reports of bacterial resistance. Betamethasone valerate: Always consider possible systemic absorption during treatment. Reports of visual disturbance. Risk of reversible hypothalamic-pituitary-adrenal (HPA) axis suppression following systemic absorption. Risk of atrophic changes on the face after prolonged treatment. Risk of raised IOP & glaucoma after use near the eyes, particularly w/ prolonged use & in patients predisposed to developing glaucoma.
Click to view Fucicort detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Fucicort detailed prescribing information
Storage
View Fucicort storage conditions for details to ensure optimal shelf-life.
Description
View Fucicort description for details of the chemical structure and excipients (inactive components).
Action
View Fucicort mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Topical Anti-Infectives with Corticosteroids
ATC Classification
D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent (group III) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
Fucicort cream
Packing/Price
15 g x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in